SEK 14.88
(-5.46%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -3.73 SEK | 27.85% |
2022 | -5.17 SEK | 20.58% |
2021 | -6.51 SEK | -165.71% |
2020 | -2.45 SEK | -138.7% |
2019 | 6.33 SEK | 58.65% |
2018 | 3.99 SEK | 495.52% |
2017 | 0.67 SEK | -20.24% |
2016 | 0.84 SEK | 114.63% |
2015 | -5.74 SEK | -231.79% |
2014 | -1.73 SEK | 66.47% |
2013 | -5.16 SEK | -76.71% |
2012 | -2.92 SEK | 79.76% |
2011 | -14.43 SEK | -278.74% |
2010 | -3.81 SEK | 11.81% |
2009 | -4.32 SEK | 9.24% |
2008 | -4.76 SEK | 0.0% |
2007 | - SEK | 100.0% |
2006 | -2.46 SEK | 24.54% |
2005 | -3.26 SEK | 99.28% |
2004 | -450.66 SEK | 54.06% |
2003 | -980.88 SEK | -18.08% |
2002 | -830.66 SEK | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -0.26 SEK | 51.85% |
2024 Q2 | -1.04 SEK | -300.0% |
2024 Q3 | -1.21 SEK | -16.35% |
2023 Q3 | -0.97 SEK | -162.16% |
2023 Q4 | -0.54 SEK | 44.33% |
2023 FY | - SEK | 27.85% |
2023 Q2 | -0.37 SEK | 80.11% |
2023 Q1 | -1.86 SEK | 30.34% |
2022 Q1 | -0.69 SEK | 64.25% |
2022 Q2 | -1.04 SEK | -50.72% |
2022 Q3 | -0.77 SEK | 25.96% |
2022 Q4 | -2.67 SEK | -246.75% |
2022 FY | - SEK | 20.58% |
2021 FY | - SEK | -165.71% |
2021 Q1 | -0.92 SEK | 37.84% |
2021 Q2 | -2.15 SEK | -133.7% |
2021 Q4 | -1.93 SEK | -27.81% |
2021 Q3 | -1.51 SEK | 29.77% |
2020 Q3 | -2.45 SEK | -160.64% |
2020 Q1 | 2.38 SEK | 112.5% |
2020 FY | - SEK | -138.7% |
2020 Q2 | -0.94 SEK | -139.5% |
2020 Q4 | -1.48 SEK | 39.59% |
2019 Q2 | 1.54 SEK | 275.61% |
2019 Q3 | 3.22 SEK | 109.09% |
2019 Q4 | 1.12 SEK | -65.22% |
2019 FY | - SEK | 58.65% |
2019 Q1 | 0.41 SEK | -72.48% |
2018 Q3 | 1.80 SEK | 24.14% |
2018 FY | - SEK | 495.52% |
2018 Q2 | 1.45 SEK | 293.33% |
2018 Q4 | 1.49 SEK | -17.22% |
2018 Q1 | -0.75 SEK | -197.4% |
2017 Q3 | 0.82 SEK | 811.11% |
2017 Q2 | 0.09 SEK | 109.0% |
2017 Q1 | -1.00 SEK | -203.09% |
2017 FY | - SEK | -20.24% |
2017 Q4 | 0.77 SEK | -6.1% |
2016 FY | - SEK | 114.63% |
2016 Q3 | 1.04 SEK | 642.86% |
2016 Q2 | 0.14 SEK | 114.0% |
2016 Q1 | -1.00 SEK | 33.33% |
2016 Q4 | 0.97 SEK | -6.73% |
2015 FY | - SEK | -231.79% |
2015 Q1 | -0.45 SEK | -130.0% |
2015 Q2 | -2.46 SEK | -446.67% |
2015 Q3 | -1.33 SEK | 45.93% |
2015 Q4 | -1.50 SEK | -12.78% |
2014 Q2 | -1.58 SEK | -139.39% |
2014 Q4 | 1.50 SEK | 240.19% |
2014 FY | - SEK | 66.47% |
2014 Q3 | -1.07 SEK | 32.28% |
2014 Q1 | -0.66 SEK | 44.54% |
2013 Q1 | 0.95 SEK | 223.38% |
2013 Q2 | -4.00 SEK | -521.05% |
2013 Q4 | -1.19 SEK | -29.35% |
2013 Q3 | -0.92 SEK | 77.0% |
2013 FY | - SEK | -76.71% |
2012 FY | - SEK | 79.76% |
2012 Q4 | -0.77 SEK | 28.04% |
2012 Q2 | -0.56 SEK | -3.7% |
2012 Q3 | -1.07 SEK | -91.07% |
2012 Q1 | -0.54 SEK | 94.05% |
2011 FY | - SEK | -278.74% |
2011 Q4 | -9.07 SEK | -385.03% |
2011 Q3 | -1.87 SEK | -83.33% |
2011 Q2 | -1.02 SEK | 38.92% |
2011 Q1 | -1.67 SEK | -1935.16% |
2010 Q3 | -1.22 SEK | 19.21% |
2010 Q1 | -1.18 SEK | 52.42% |
2010 FY | - SEK | 11.81% |
2010 Q2 | -1.51 SEK | -27.97% |
2010 Q4 | 0.09 SEK | 107.46% |
2009 FY | - SEK | 9.24% |
2009 Q1 | 1.20 SEK | 281.82% |
2009 Q2 | -2.53 SEK | -310.83% |
2009 Q3 | -0.42 SEK | 83.4% |
2009 Q4 | -2.48 SEK | -490.48% |
2008 Q3 | 0.09 SEK | 0.0% |
2008 Q4 | -0.66 SEK | -833.33% |
2008 FY | - SEK | 0.0% |
2007 FY | - SEK | 100.0% |
2006 FY | - SEK | 24.54% |
2005 FY | - SEK | 99.28% |
2004 FY | - SEK | 54.06% |
2003 FY | - SEK | -18.08% |
2002 FY | - SEK | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
AcuCort AB | -0.16 SEK | -2231.25% |
AlzeCure Pharma AB (publ) | -0.60 SEK | -521.667% |
BioGaia AB (publ) | 3.62 SEK | 203.039% |
Enzymatica AB (publ) | -0.28 SEK | -1232.143% |
Enorama Pharma AB (publ) | -1.61 SEK | -131.677% |
Gabather AB (publ) | -0.65 SEK | -473.846% |
Klaria Pharma Holding AB (publ.) | -0.36 SEK | -936.111% |
Moberg Pharma AB (publ) | -1.33 SEK | -180.451% |
Nanexa AB (publ) | -1.09 SEK | -242.202% |
Newbury Pharmaceuticals AB (publ) | -0.72 SEK | -418.056% |
ODI Pharma AB | 0.02 SEK | 16040.171% |
Probi AB (publ) | 1.48 SEK | 352.027% |
Swedencare AB (publ) | 0.37 SEK | 1108.108% |
Swedish Orphan Biovitrum AB (publ) | 7.47 SEK | 149.933% |
Toleranzia AB | -0.06 SEK | -6560.714% |
Vivesto AB | -0.74 SEK | -404.054% |